139 related articles for article (PubMed ID: 15072589)
21. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.
Tanaka T; Kohno H; Suzuki R; Yamada Y; Sugie S; Mori H
Cancer Sci; 2003 Nov; 94(11):965-73. PubMed ID: 14611673
[TBL] [Abstract][Full Text] [Related]
22. Initial levels of azoxymethane-induced DNA methyl adducts are not predictive of tumor susceptibility in inbred mice.
Papanikolaou A; Shank RC; Delker DA; Povey A; Cooper DP; Rosenberg DW
Toxicol Appl Pharmacol; 1998 May; 150(1):196-203. PubMed ID: 9630469
[TBL] [Abstract][Full Text] [Related]
23. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
[TBL] [Abstract][Full Text] [Related]
24. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
[TBL] [Abstract][Full Text] [Related]
25. Effect of 2-(carboxyphenyl) retinamide and genistein on the formation of early lesions in 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.
Zhi H; Yamada Y; Hirose Y; Kato K; Sheng H; Zheng Q; Oyama T; Asano N; Kuno T; Hara A; Mori H
Asian Pac J Cancer Prev; 2007; 8(1):33-8. PubMed ID: 17477768
[TBL] [Abstract][Full Text] [Related]
26. Enhancement by thyroxine of experimental carcinogenesis induced in rat colon by azoxymethane.
Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H
Int J Cancer; 1992 Apr; 50(6):974-6. PubMed ID: 1555896
[TBL] [Abstract][Full Text] [Related]
27. Multistage gene expression profiling in a differentially susceptible mouse colon cancer model.
Guda K; Cui H; Garg S; Dong M; Nambiar PR; Achenie LE; Rosenberg DW
Cancer Lett; 2003 Feb; 191(1):17-25. PubMed ID: 12609705
[TBL] [Abstract][Full Text] [Related]
28. Lack of enhancing effects of degraded lambda-carrageenan on the development of beta-catenin-accumulated crypts in male DBA/2J mice initiated with azoxymethane.
Hata K; Tanaka T; Kohno H; Suzuki R; Qiang SH; Kuno T; Hirose Y; Hara A; Mori H
Cancer Lett; 2006 Jul; 238(1):69-75. PubMed ID: 16046055
[TBL] [Abstract][Full Text] [Related]
29. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth.
Ghirardi M; Nascimbeni R; Villanacci V; Fontana MG; Di Betta E; Salerni B
Eur Surg Res; 1999; 31(3):272-80. PubMed ID: 10352356
[TBL] [Abstract][Full Text] [Related]
30. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
Yamada Y; Yoshimi N; Hirose Y; Hara A; Shimizu M; Kuno T; Katayama M; Qiao Z; Mori H
Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
[TBL] [Abstract][Full Text] [Related]
31. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors.
Guda K; Giardina C; Nambiar P; Cui H; Rosenberg DW
Mol Carcinog; 2001 Aug; 31(4):204-13. PubMed ID: 11536370
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
[TBL] [Abstract][Full Text] [Related]
33. Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse.
MacGregor DJ; Kim YS; Sleisenger MH; Johnson LK
Int J Oncol; 2000 Jul; 17(1):173-9. PubMed ID: 10853036
[TBL] [Abstract][Full Text] [Related]
34. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
[TBL] [Abstract][Full Text] [Related]
35. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats.
Shih CK; Chiang W; Kuo ML
Food Chem Toxicol; 2004 Aug; 42(8):1339-47. PubMed ID: 15207385
[TBL] [Abstract][Full Text] [Related]
36. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
Mori H; Yamada Y; Kuno T; Hirose Y
Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
[TBL] [Abstract][Full Text] [Related]
37. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
Whiteley LO; Hudson L; Pretlow TP
Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
[TBL] [Abstract][Full Text] [Related]
38. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
39. Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane.
Nozaki T; Fujihara H; Watanabe M; Tsutsumi M; Nakamoto K; Kusuoka O; Kamada N; Suzuki H; Nakagama H; Sugimura T; Masutani M
Cancer Sci; 2003 Jun; 94(6):497-500. PubMed ID: 12824873
[TBL] [Abstract][Full Text] [Related]
40. Cyclophilin C-associated protein (CyCAP) knock-out mice spontaneously develop colonic mucosal hyperplasia and exaggerated tumorigenesis after treatment with carcinogen azoxymethane.
Torlakovic EE; Keeler V; Wang C; Lim HJ; Lining LA; Laferté S
BMC Cancer; 2009 Jul; 9():251. PubMed ID: 19627619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
